» Articles » PMID: 37608291

The Cost Effectiveness of Intensity-modulated Radiation Therapy and Three-dimensional Conformal Radiotherapy in the Treatment of Head and Neck Cancers

Overview
Journal Radiat Oncol
Publisher Biomed Central
Specialties Oncology
Radiology
Date 2023 Aug 23
PMID 37608291
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Intensity-modulated radiotherapy is developed as a replacement for 3-dimensional conformal radiation therapy. Considering the difference in costs and effectiveness of these interventions, the aim of this study was to compare the cost effectiveness of intensity-modulated radiation therapy and three-dimensional conformal radiotherapy in the treatment of head and neck cancer in east of Iran.

Methods: A Markov model including six states based on xerostomia and dysphagia was developed to estimate the incremental cost effectiveness ratio from the perspective of societal. Cost and quality of life data were collected from 97 respondents via a checklist and EuroQol-5Dimension questionnaire. The robustness of results was examined by deterministic and probabilistic sensitivity analysis. All analysis were conducted with Treeage software.

Results: The results of this study showed that the cost and quality adjusted life years for 3-dimensional conformal radiation therapy were 9209.76 and 3.63 respectively. However, the cost and quality adjusted life years for intensity-modulated radiotherapy were 12562.90 and 3.17 respectively. Therefore, 3-dimensional conformal radiation therapy produced 0.45 more quality adjusted life years than intensity-modulated radiotherapy and saved $3353. According to the incremental cost effectiveness ratio, 3-dimensional conformal radiation therapy as compared to intensity-modulated radiotherapy saved $7367.27 per quality adjusted life years. These results confirmed by sensitivity analysis.

Conclusion: This study concluded that in the treatment of head and neck cancer, the 3-dimensional conformal radiation therapy method appears to be cost-effective when compared with intensity-modulated radiotherapy.

Citing Articles

Gamma Knife Radiosurgery for optic nerve sheath meningioma: comparison of efficacy and costs with radiotherapy under Korean health insurance system.

Ma S, Ahn Y, Lim D, Lee J, Seol H, Lee W J Neurooncol. 2025; .

PMID: 40069531 DOI: 10.1007/s11060-025-04986-2.

References
1.
Roshandel G, Ghanbari-Motlagh A, Partovipour E, Salavati F, Hasanpour-Heidari S, Mohammadi G . Cancer incidence in Iran in 2014: Results of the Iranian National Population-based Cancer Registry. Cancer Epidemiol. 2019; 61:50-58. DOI: 10.1016/j.canep.2019.05.009. View

2.
Nutting C, Morden J, Harrington K, Urbano T, Bhide S, Clark C . Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol. 2011; 12(2):127-36. PMC: 3033533. DOI: 10.1016/S1470-2045(10)70290-4. View

3.
Moreno A, Frank S, Garden A, Rosenthal D, Fuller C, Gunn G . Intensity modulated proton therapy (IMPT) - The future of IMRT for head and neck cancer. Oral Oncol. 2019; 88:66-74. PMC: 6615027. DOI: 10.1016/j.oraloncology.2018.11.015. View

4.
Sheets N, Wheeler S, Kohler R, Fried D, Brown P, Chera B . Costs of care in a matched pair comparison of intensity-modulated radiation therapy (IMRT) versus conventional radiation therapy (CRT) for the treatment of head and neck cancer. Am J Clin Oncol. 2013; 37(6):539-44. DOI: 10.1097/COC.0b013e318282a850. View

5.
Chauhan A, Prinja S, Ghoshal S, Verma R, Oinam A . Cost of treatment for head and neck cancer in India. PLoS One. 2018; 13(1):e0191132. PMC: 5764364. DOI: 10.1371/journal.pone.0191132. View